Alpha Teknova, Inc. (TKNO)

USD 6.52

(-1.36%)

Market Cap (In USD)

348.43 Million

Revenue (In USD)

36.68 Million

Net Income (In USD)

-36.78 Million

Avg. Volume

444.82 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.155-8.909
PE
-11.44
EPS
-0.57
Beta Value
0.359
ISIN
US02080L1026
CUSIP
02080L102
CIK
1850902
Shares
53440800.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Stephen Gunstream
Employee Count
-
Website
https://www.teknova.com
Ipo Date
2021-06-25
Details
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.